TABLE 3.
Region | Both sexes | Men | Women | |||
---|---|---|---|---|---|---|
Prevalence % (95% CI) | I2, P‐value | Prevalence % (95% CI) | I2, P‐value | Prevalence % (95% CI) | I2, P‐value | |
Nation‐wide | ||||||
Hypertension | 30.6 (27.3‐34.0) | 99.1, <.001 | 29.5 (25.4‐33.6) | 98.2, <.001 | 30.4 (25.2‐35.6) | 99.2, <.001 |
Pre‐hypertension | 30.9 (22.0‐39.6) | 99.3, <.001 | ‐ | ‐ | ‐ | ‐ |
Awareness a | 29.0 (19.7‐38.3) | 98.9, <.001 | ‐ | ‐ | ‐ | ‐ |
Treatment a | 12.0 (2.7‐21.2) | 97.9, <.001 | ‐ | ‐ | ‐ | ‐ |
Control a | 2.8 (0.0‐5.7) | 83.1, .015 | ‐ | ‐ | ‐ | ‐ |
SBP (mmHg) | 130.9 (128.4‐133.4) | 90.7, <.001 | ‐ | ‐ | ‐ | ‐ |
DBP (mmHg) | 81.1 (79.5‐82.8) | 95.0, <.001 | ‐ | ‐ | ‐ | ‐ |
Geopolitical zone | ||||||
North‐central | 32.2 (13.5‐34.0) | 99.1, <.001 | 35.9 (21.6‐50.2) | 93.3, <.001 | 24.8 (21.3‐28.4) | 97.1, <.001 |
North‐east | 24.7(22.4‐27.1) | 0.0, .457 | 23.3 (19.5‐27.1) | 28.7. .236 | 24.8 (21.3‐28.4) | 0.0, .867 |
North‐west | 31.9 (14.9‐48.9) | 97.7, <.001 | 20.1 (7.2‐33.1) | 90.9, <.001 | 34.0 (13.9‐54.1) | 97.2, <.001 |
South‐east | 33.3 (27.3‐39.4) | 99.0, <.001 | 40.8 (33.7‐48.0) | 95.1, <.001 | 35.8 (29.0‐42.6) | 96.1, <.001 |
South‐south | 27.6 (21.4‐33.9) | 98.3, <.001 | 24.4 (18.9‐29.8) | 92.2, <.001 | 20.9 (15.6‐26.3) | 94.6, <.001 |
South‐west | 30.2 (23.6‐36.8) | 99.2, <.001 | 27.3 (17.3‐37.2) | 98.0, <.001 | 30.9 (20.0‐41.8) | 99.4, <.001 |
Settings | ||||||
Urban | 33.6 (25.1‐42.0) | 98.8, <.001 | 27.2 (17.3‐37.2) | 97.9, <.001 | 34.5 (23.2‐45.8) | 98.3, <.001 |
Rural | 25.5 (21.1‐29.9) | 98.6, <.001 | 26.4 (20.6‐32.2) | 94.5, <.001 | 22.9 (17.8‐28.1) | 95.5, <.001 |
Mixed | 33.7 (26.7‐40.7) | 99.3, <.001 | 35.8 (27.8‐43.7) | 98.6, <.001 | 34.1 (25.0‐43.1) | 99.1, <.001 |
Awareness, treatment, and control rates expressed as percent of HTN cases.